{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-21-004078","form_type":"8-K","ticker":"RXST","cik":"0001111485","company_name":"RxSight, Inc.","filed_at":"2021-11-10T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.535652+00:00","generated_at":"2026-06-28T09:43:50.849042+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"RxSight Q3 2021 revenue $5.8M (+39% YoY); net loss $12.7M; FY revenue guidance $21.0-$21.4M","bullets":["Q3 revenue $5.8M, up 39% YoY and 18% QoQ; 31 LDDs sold, installed base 161.","Net loss $(12.7)M ($(0.68)/share) vs net income $5.9M in Q3 2020; adjusted net loss $(12.2)M ($(0.65)/share).","Cash and investments $168.3M; long-term debt $39.6M as of Sep 30, 2021.","FY 2021 revenue guidance $21.0M-$21.4M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-21-004078","json":"https://secwatch.observer/filing/0000950170-21-004078.json","markdown":"https://secwatch.observer/filing/0000950170-21-004078.md","text":"https://secwatch.observer/filing/0000950170-21-004078.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1111485/000095017021004078/0000950170-21-004078-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1111485/000095017021004078/rxst-20211110.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T09:43:50.849042+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}